Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cytotoxicity of water-soluble fullerene in vascular endothelial cells

View through CrossRef
Nanoscale materials are presently under development for diagnostic (nanomedicine) and electronic purposes. In contrast to the potential benefits of nanotechnology, the effects of nanomaterials on human health are poorly understood. Nanomaterials are known to translocate into the circulation and could thus directly affect vascular endothelial cells (ECs), causing vascular injury that might be responsible for the development of atherosclerosis. To explore the direct effects of nanomaterials on endothelial toxicity, human umbilical vein ECs were treated with 1–100 μg/ml hydroxyl fullerene [C60(OH)24; mean diameter, 7.1 ± 2.4 nm] for 24 h. C60(OH)24 induced cytotoxic morphological changes such as cytosolic vacuole formation and decreased cell density in a dose-dependent manner. Lactate dehydrogenase assay revealed that a maximal dose of C60(OH)24 (100 μg/ml) induced cytotoxic injury. Proliferation assay also showed that a maximal dose of C60(OH)24 inhibited EC growth. C60(OH)24 did not seem to induce apoptosis but caused the accumulation of polyubiquitinated proteins and facilitated autophagic cell death. Formation of autophagosomes was confirmed on the basis of Western blot analysis using a specific marker, light chain 3 antibody, and electron microscopy. Chronic treatment with low-dose C60(OH)24 (10 μg/ml for 8 days) inhibited cell attachment and delayed EC growth. In the present study, we have examined, for the first time, the toxicity of water-soluble fullerenes to ECs. Although fullerenes changed morphology in a dose-dependent manner, only maximal doses of fullerenes caused cytotoxic injury and/or death and inhibited cell growth. EC death seemed to be caused by activation of ubiquitin-autophagy cell death pathways. Although exposure to nanomaterials appears to represent a risk for cardiovascular disorders, further in vivo validations are necessary.
Title: Cytotoxicity of water-soluble fullerene in vascular endothelial cells
Description:
Nanoscale materials are presently under development for diagnostic (nanomedicine) and electronic purposes.
In contrast to the potential benefits of nanotechnology, the effects of nanomaterials on human health are poorly understood.
Nanomaterials are known to translocate into the circulation and could thus directly affect vascular endothelial cells (ECs), causing vascular injury that might be responsible for the development of atherosclerosis.
To explore the direct effects of nanomaterials on endothelial toxicity, human umbilical vein ECs were treated with 1–100 μg/ml hydroxyl fullerene [C60(OH)24; mean diameter, 7.
1 ± 2.
4 nm] for 24 h.
C60(OH)24 induced cytotoxic morphological changes such as cytosolic vacuole formation and decreased cell density in a dose-dependent manner.
Lactate dehydrogenase assay revealed that a maximal dose of C60(OH)24 (100 μg/ml) induced cytotoxic injury.
Proliferation assay also showed that a maximal dose of C60(OH)24 inhibited EC growth.
C60(OH)24 did not seem to induce apoptosis but caused the accumulation of polyubiquitinated proteins and facilitated autophagic cell death.
Formation of autophagosomes was confirmed on the basis of Western blot analysis using a specific marker, light chain 3 antibody, and electron microscopy.
Chronic treatment with low-dose C60(OH)24 (10 μg/ml for 8 days) inhibited cell attachment and delayed EC growth.
In the present study, we have examined, for the first time, the toxicity of water-soluble fullerenes to ECs.
Although fullerenes changed morphology in a dose-dependent manner, only maximal doses of fullerenes caused cytotoxic injury and/or death and inhibited cell growth.
EC death seemed to be caused by activation of ubiquitin-autophagy cell death pathways.
Although exposure to nanomaterials appears to represent a risk for cardiovascular disorders, further in vivo validations are necessary.

Related Results

Bone Marrow Granulocytes Drive Vascular and Hematopoietic Regeneration
Bone Marrow Granulocytes Drive Vascular and Hematopoietic Regeneration
Abstract In addition to eliminating host hematopoietic cells myeloablation also disrupts the blood vessels that sustain hematopoiesis. Regeneration of the bone marro...
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
C. Christov, H. Adle‐Biassette, C. Le Guerinel, S. Natchev and R. K. Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endot...
Endothelial Cell‐Secreted Semaphorin 3F Promotes Proximal Tubule Cell Maturation and Polarization
Endothelial Cell‐Secreted Semaphorin 3F Promotes Proximal Tubule Cell Maturation and Polarization
Endothelial cells secrete trophic factors that contribute to the maturation of surrounding tissues. The notion of the microvasculature as niche for local differentiation and homeos...
Abstract 1777: A non-signaling CAR for gamma-delta (γδ) T cells to preserve healthy tissues
Abstract 1777: A non-signaling CAR for gamma-delta (γδ) T cells to preserve healthy tissues
Abstract Chimeric antigen receptor T cell (CAR-T) therapy for B cell leukemias and lymphomas have shown remarkable responses in the clinic. However, the elimination ...
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
AbstractRationaleThe secondary thrombotic/vascular clinical syndrome of COVID-19 suggests that SARS-CoV-2 infects not only respiratory epithelium but also the endothelium activatin...
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
Breast Cancer Susceptibility Gene 2 Deficiency Exacerbates Angiotensin‐II‐induced Endothelial Dysfunction and Apoptosis
BackgroundGerm‐line mutations in the tumour suppressor genes BRCA1 and BRCA2 (BReast CAncer susceptibility genes 1 & 2) predispose carriers to breast cancer. BRCA1 and BRCA2 he...

Back to Top